Sign in
8-K

Current Report

Protalix BioTherapeutics, Inc. Filed Acc 0001144204-12-003991

Regulation FD disclosure

  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading v300324_8k.htm…